Wordt geladen...
FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation
Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplantation (HCT) is associated with high mortality. Purpose: We hypothesized that FAM (inhaled Fluticasone, Azithromycin, and Montelukast) with a brief steroid pulse could avert progression of new-onset BOS. Experimenta...
Bewaard in:
| Gepubliceerd in: | Biol Blood Marrow Transplant |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4801753/ https://ncbi.nlm.nih.gov/pubmed/26475726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.10.009 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|